Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics

Our findings suggest that immune dysregulation, characterized by increased plasmablasts and reduced pDC and NK cell responses, contributes to COVID-19 severity. Strong pDC and NK cell responses may confer protection against SARS-CoV-2. These insights into immune responses may inform strategies for therapeutic interventions and vaccine development.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-01-07
DOI
https://doi.org/10.3389/fimmu.2025.1693903
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics

Roberto Pariente, Laura Luna, Paulette Esperanza Walo-Delgado, Ana del Amo-de Palacios et al.
Frontiers in Immunology
SARS-CoV-2 and COVID-19 Research
article

Contrasting immune responses in COVID-19: insights from healthcare workers and infected patients on plasmablast, pDC, and NK cell dynamics

Roberto Pariente, Laura Luna, Paulette Esperanza Walo-Delgado, Ana del Amo-de Palacios, Javier García‐Pérez, E Rodríguez-Martín, LUISA MARÍA VILLAR, Janepsy Díaz, Sergio Serrano-Villar, José Alcamí, Erick De La Torre-Tarazona, Mario Rodríguez-Dominguez, Juan Carlos Galán, Santiago Moreno, Claudia Geraldine Rita, María Fons, Elena Moreno, Roser Navarro-Soler, Laura Martín-Pedraza
article en

Abstract

Our findings suggest that immune dysregulation, characterized by increased plasmablasts and reduced pDC and NK cell responses, contributes to COVID-19 severity. Strong pDC and NK cell responses may confer protection against SARS-CoV-2. These insights into immune responses may inform strategies for therapeutic interventions and vaccine development.

Frontiers in ImmunologyVol. 16
Universidad de Alcalá (ES), Instituto Cajal (ES), Instituto de Salud Carlos III (ES), Universidad Nebrija (ES), Centro de Investigación en Red en Enfermedades Cardiovasculares (ES), Instituto Ramón y Cajal de Investigación Sanitaria (ES), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), Hospital Universitario Ramón y Cajal (ES)
Instituto de Salud Carlos III, European Regional Development Fund
Good health and well-being
Openalex Percentile: Top 96%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.